Inhibiting USP22 Halts Periodontitis-Linked Brain Inflammation in Mice

Epidemiological and preclinical data increasingly link chronic periodontitis to central nervous system disorders, including Alzheimer's disease, with severe gum disease elevating the odds of cognitive decline [1, 2]. The keystone periodontal pathogen Porphyromonas gingivalis and its toxic byproducts have been detected directly in human brain tissue, where they correlate with amyloid-beta accumulation, tau hyperphosphorylation, and microglial activation [3, 4]. While the clinical association between oral dysbiosis and neuroinflammation is well documented, the exact anatomical pathways these pathogens exploit to breach the central nervous system remain incompletely mapped. Understanding how systemic oral bacteria compromise the blood-brain barrier is critical for developing interventions that protect neurological function in vulnerable patients. A recent study offers fresh insights into the specific cellular transitions that allow these oral pathogens to degrade cerebrovascular integrity, highlighting a potential therapeutic target for mitigating cognitive risk in patients with severe dental disease.